Bleeding Events In Lusutrombopag-Treated Thrombocytopenic Patients
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION(2021)
摘要
Patients with advanced chronic liver disease are characterised by the presence of thrombocytopoenia in a proportion ranging from 15% to 84%, depending on the threshold used to define this abnormality and the degree of severity of liver disease. In these patients, thrombocytopoenia is multifactorial and may be associated with an increased risk of bleeding following invasive procedures. Indeed, although the platelet count threshold associated with an increased risk of bleeding is debated, current practice guidelines suggest platelet transfusions, or the use of thrombopoietin receptor agonists (TPO-RA), prior to high-risk planned invasive procedures, in patients with chronic liver disease and a platelet count <50 x 10 /L..
更多查看译文
关键词
bleeding, invasive procedures, liver disease, platelets, thrombocytopenia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要